Responsible for growing and enhancing Advanced Diagnostics, based on molecular diagnostics requiring special expertise in Oncology; Successfully manage all sales of Oncology portfolio in Midwest and West Regions; Developed stronger sales team and created tactical plans necessary for delivering exceptional sales results; Designed vision and executed efficient strategies that transformed an Oncology sales organization with growth exceeding expectations.

Recruited by CEO and CCO to manage the development of the commercial infrastructure and become head of the U.S. sales upon full commercialization. Exceeded 2014 goals by identifying over 50 hospitals that were Early Adopter’s following FDA clearance. Obtained commitment at each hospital for our product from Chief of Emergency Department as well as other decision making executives, including CEO, CFO, CMO and Medical Director’s; Provided leadership as a key player on the team to help champion Venaxis’ strategy/response to the FDA “AI” inquiry; Recruited 10 key opinion leaders to influence industry, write scientific papers and lead additional studies, post-FDA; Defined, documented and tested all sales process steps required to sell our test into the U.S. market and globally; Identified and developed partnerships, built sales plan and pitch, designed the hiring and training programs and developed a detailed best in class Performance Management System.

Hired by the CEO to turnaround an under-performing sales and commercial organization with particular emphasis on driving U.S. sales growth, profitability and staff development.Ferno Group Company of Year Award for Top Sales & Growth in 2013; Full P&L responsibility and direct management of sales, business development, distribution, training, education/service and customer service that consists of (4) Directors, (20) Senior Sales Specialists, (8) Customer Experience Specialists and Support staff; Led the reorganization of commercial sales team with a portfolio of 3000+ products that allowed the U.S. Division to increase direct sales by 35% and also improved EBIT by 10%; Developed strong business partnerships with a national distributor and other strategic alliances which increased overall revenue by $10MM in 2 years; Created a Leadership Development Program to reward high potential/high performing personnel throughout the organization which resulted in formalizing career pathways for advancement opportunities globally; Restructured and realigned customer service organization to reflect our long-term business strategy by transforming the team into an inside sales and customer experience department; Successfully launched into a new hospital market segment that resulted in $7MM of new revenue within 2 years.

Siemens purchased Bayer Diagnostics in 2005. Managed and directed overall global business for Quest Diagnostics (Bayer’s largest global customer) which generated $100MM in revenue; 15% of total U.S. revenue; Turned around stalled businesses in Molecular, Immunoassay and Urinalysis product lines and increased revenue by $15MM in 1st year; Negotiated and closed $96MM Immunoassay contract, largest sale in Bayer history

Responsible for capital sales of chemistry, immunochemistry and hematology products; Increased cumulative over target sales of immunochemistry business by 123% in 1999; Increased business $600K and finished 10th out of 99 sales personnel in 1998